IM Cannabis Corp (IMCC) to Acquire Oranim, Jerusalem's Leading Medical Cannabis Pharmacy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/26/2024
- Stocks face worst month since September, yen swings after BoJ
- Microsoft fiscal Q3 results top estimates as AI revolution spurs cloud growth
- Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
- Intel slides in afterhours trading as Q1 revenue misses, Q2 outlook falls short
- Oil prices on track to snap two-week losing streak
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
- Union Pacific beats profit estimates on stronger pricing, resumes share buyback
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hertz Global (HTZ) misses earnings expectations as fleet costs weigh
- Teladoc (TDOC) Misses Q1 EPS by 3c, offers outlook
- After-hours movers: Alphabet, Microsoft, Snap, Intel, and more
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
IM Cannabis to Acquire Oranim, Jerusalem's Leading Medical Cannabis Pharmacy
December 1, 2021 8:17 AM ESTTransaction positions IM Cannabis as one of the largest retailers of medical cannabis in Israel; Retail segment combined annualized revenue of approximately $44 million
Oranim's trailing 12-month revenue approximately $16.5 million and gross margin approximately 25%[1] before recognizing synergies
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / December 1, 2021 / IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE: IMCC), (NASDAQ: IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel,... More
